Port Therapeutics is a stealth venture-backed biotechnology company launched by co-founders Gabe Kwong (Georgia Tech), Mikhail Shapiro (Caltech, HHMI) and Sangeeta Bhatia (MIT, HHMI). Port Therapeutics was founded with the vision to merge breakthrough advances in synthetic biology, cell engineering, and clinical imaging to enable safer, more precise and potent therapies.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 1927 Paseo Rancho Castilla, Los Angeles,california 90032,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://porttherapeutics.com/
- HQ
- Los Angeles, California
Port Therapeutics Questions
Port Therapeutics's website is https://porttherapeutics.com/
Port Therapeutics's LinkedIn profile is https://www.linkedin.com/company/porttherapeutics
Port Therapeutics has
6 employees.
View email and phone details for 6
employees at Port Therapeutics.
Port Therapeutics's industry is
Biotechnology Research
Port Therapeutics's top competitors are
Bioivt,
Paratus Sciences,
Matrisome Bio,
Clade Therapeutics,
Hepregen Corporation,
Verasonics®,
Sunbird Bio,
Ropirio Therapeutics, Inc.,
Satellite Bio,
Amplifyer Bio.
Port Therapeutics's categories are Biotechnology Research
Port Therapeutics's founding year is 2021
